The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

Contribution and clinical relevance of germline variation to the cancer transcriptome

18 p | 9 | 3

Haplotype-resolved germline and somatic alterations in renal medullary carcinomas

13 p | 3 | 2

The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database

6 p | 15 | 1

Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non‑carriers: A matched‑pair analysis

12 p | 1 | 1

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: A qualitative study of barriers to implementation

8 p | 9 | 0